+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region: Trend Forecast and Growth Opportunity

  • ID: 5310292
  • Report
  • March 2021
  • Region: Global
  • 185 pages
  • GMD Research

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer, Inc.
Global pharmaceutical manufacturing industry will reach $673.6 billion by 2027, growing by 12.5% annually over 2020-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.

Highlighted with 85 tables and 96 figures, this 185-page report “Global Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Industry Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Industry Opportunities
  • Porter’s Fiver Forces
The trend and outlook of global industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region.

Based on Formulation, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations
Based on Route of Administration, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Oral Medicine
  • Topical Medicine
  • Parenteral Medicine
  • Inhalations
  • Other Routes of Administration
Based on Age Group, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Children & Adolescents
  • Adults
  • Geriatric
Based on Therapeutic Application, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Cardiovascular Diseases
  • Pain
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Neurological Diseases
  • Orthopedics
  • Other Applications
Based on Drug Type, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs
Based on Distribution Channels, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • Retail Channels
  • Non-retail Channels
Based on Manufacturing Facility, the global industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
  • In-house Facility
  • Outsourced Facility
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • North America (U.S. Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of all regional markets by country and split of key national industry by Formulation, Route of Administration, and Drug Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including industry leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical manufacturing industry are assayed quantitatively and qualitatively through a proprietary Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Abbott Laboratories
  • Aenova Group
  • Amgen
  • AstraZeneca
  • Catalent Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lonza Group
  • Lupin
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk
  • Pfizer, Inc.
  • Roche
  • Sanofi SA
  • Takeda
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer, Inc.
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Industry Research Methodology
1.2.2 Industry Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Industry Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Industry Overview and Dynamics
2.1 Industry Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Industry
2.2 Major Growth Drivers
2.3 Industry Restraints and Challenges
2.4 Emerging Opportunities and Industry Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Industry by Formulation
3.1 Industry Overview by Formulation
3.2 Tablets
3.3 Capsules
3.4 Injectable
3.5 Sprays
3.6 Suspensions
3.7 Powders
3.8 Other Formulations

4 Segmentation of Global Industry by Route of Administration
4.1 Industry Overview by Route of Administration
4.2 Oral Medicine
4.3 Topical Medicine
4.4 Parenteral Medicine
4.5 Inhalations
4.6 Other Routes of Administration

5 Segmentation of Global Industry by Age Group
5.1 Industry Overview by Age Group
5.2 Children & Adolescents
5.3 Adults
5.4 Geriatric

6 Segmentation of Global Industry by Therapeutic Application
6.1 Industry Overview by Therapeutic Application
6.2 Cardiovascular Diseases
6.3 Pain
6.4 Diabetes
6.5 Cancer
6.6 Respiratory Diseases
6.7 Neurological Diseases
6.8 Orthopedics
6.9 Other Applications

7 Segmentation of Global Industry by Drug Type
7.1 Industry Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs

8 Segmentation of Global Industry by Distribution Channels
8.1 Industry Overview by Distribution Channels
8.2 Retail Channels
8.3 Non-retail Channels

9 Segmentation of Global Industry by Manufacturing Facility
9.1 Industry Overview by Manufacturing Facility
9.2 In-house Facility
9.3 Outsourced Facility

10 Segmentation of Global Industry by Region
10.1 Geographic Industry Overview 2020-2027
10.2 North America Industry 2020-2027 by Country
10.2.1 Overview of North America Industry
10.2.2 U.S.
10.2.3 Canada
10.2.4 Mexico
10.3 European Industry 2020-2027 by Country
10.3.1 Overview of European Industry
10.3.2 UK
10.3.3 France
10.3.4 Germany
10.3.5 Spain
10.3.6 Italy
10.3.7 Russia
10.3.8 Rest of European Industry
10.4 Asia-Pacific Industry 2020-2027 by Country
10.4.1 Overview of Asia-Pacific Industry
10.4.2 China
10.4.3 Japan
10.4.4 India
10.4.5 Australia
10.4.6 South Korea
10.4.7 Rest of APAC Region
10.5 South America Industry 2020-2027 by Country
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America Industry
10.6 MEA Industry 2020-2027 by Country
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 Other National Markets

11 Competitive Landscape
11.1 Overview of Key Vendors
11.2 New Product Launch, Partnership, Investment, and M&A
11.3 Company Profiles
  • Abbott Laboratories
  • Aenova Group
  • Amgen
  • AstraZeneca
  • Catalent Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lonza Group
  • Lupin
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk
  • Pfizer, Inc.
  • Roche
  • Sanofi SA
  • Takeda
12 Investing in Global Industry: Risk Assessment and Management
12.1 Risk Evaluation of Global Industry
12.2 Critical Success Factors (CSFs)
  • Related Reports and Products
List of Tables
Table 1. Snapshot of Global Pharmaceutical Manufacturing Industry in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Industry Opportunities in Global Pharmaceutical Manufacturing Industry
Table 4. Global Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 5. Global Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 6. Global Pharmaceutical Manufacturing Industry by Age Group, 2017-2027, $ bn
Table 7. Global Pharmaceutical Manufacturing Industry by Therapeutic Application, 2017-2027, $ bn
Table 8. Global Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 9. Global Pharmaceutical Manufacturing Industry by Distribution Channels, 2017-2027, $ bn
Table 10. Global Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2017-2027, $ bn
Table 11. Global Pharmaceutical Manufacturing Industry by Region, 2017-2027, $ bn
Table 12. Leading National Pharmaceutical Manufacturing Industry, 2020 and 2027, $ bn
Table 13. North America Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn
Table 14. U.S. Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 15. U.S. Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 16. U.S. Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 17. Canada Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 18. Canada Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 19. Canada Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 20. Mexico Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 21. Mexico Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 22. Mexico Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 23. Europe Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn
Table 24. UK Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 25. UK Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 26. UK Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 27. France Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 28. France Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 29. France Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 30. Germany Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 31. Germany Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 32. Germany Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 33. Spain Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 34. Spain Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 35. Spain Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 36. Italy Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 37. Italy Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 38. Italy Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 39. Russia Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 40. Russia Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 41. Russia Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 42. Pharmaceutical Manufacturing Industry in Rest of Europe by Country, 2017-2027, $ bn
Table 43. APAC Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn
Table 44. China Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 45. China Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 46. China Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 47. Japan Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 48. Japan Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 49. Japan Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 50. India Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 51. India Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 52. India Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 53. Australia Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 54. Australia Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 55. Australia Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 56. South Korea Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 57. South Korea Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 58. South Korea Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 59. Pharmaceutical Manufacturing Industry in Rest of APAC by Country/Region, 2017-2027, $ bn
Table 60. South America Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn
Table 61. Argentina Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 62. Argentina Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 63. Argentina Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 64. Brazil Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 65. Brazil Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 66. Brazil Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 67. Chile Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 68. Chile Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 69. Chile Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 70. MEA Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn
Table 71. UAE Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 72. UAE Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 73. UAE Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 74. Saudi Arabia Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 75. Saudi Arabia Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 76. Saudi Arabia Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 77. South Africa Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn
Table 78. South Africa Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn
Table 79. South Africa Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn
Table 80. Abbott Laboratories: Company Snapshot
Table 81. Abbott Laboratories: Business Segmentation
Table 82. Abbott Laboratories: Product Portfolio
Table 83. Abbott Laboratories: Revenue, 2017-2019, $ bn
Table 84. Risk Evaluation for Investing in Global Industry, 2020-2027
Table 85. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Industry Estimation
Figure 4. Global Industry Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 5. Global Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Manufacturing Industry
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical Manufacturing Industry
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical Manufacturing Industry
Figure 11. Breakdown of Global Pharmaceutical Manufacturing Industry by Formulation, 2020-2027, % of Revenue
Figure 12. Contribution to Global 2021-2027 Cumulative Revenue by Formulation, Value ($ bn) and Share (%)
Figure 13. Global Pharmaceutical Manufacturing Industry: Tablets, 2017-2027, $ bn
Figure 14. Global Pharmaceutical Manufacturing Industry: Capsules, 2017-2027, $ bn
Figure 15. Global Pharmaceutical Manufacturing Industry: Injectable, 2017-2027, $ bn
Figure 16. Global Pharmaceutical Manufacturing Industry: Sprays, 2017-2027, $ bn
Figure 17. Global Pharmaceutical Manufacturing Industry: Suspensions, 2017-2027, $ bn
Figure 18. Global Pharmaceutical Manufacturing Industry: Powders, 2017-2027, $ bn
Figure 19. Global Pharmaceutical Manufacturing Industry: Other Formulations, 2017-2027, $ bn
Figure 20. Breakdown of Global Pharmaceutical Manufacturing Industry by Route of Administration, 2020-2027, % of Revenue
Figure 21. Contribution to Global 2021-2027 Cumulative Revenue by Route of Administration, Value ($ bn) and Share (%)
Figure 22. Global Pharmaceutical Manufacturing Industry: Oral Medicine, 2017-2027, $ bn
Figure 23. Global Pharmaceutical Manufacturing Industry: Topical Medicine, 2017-2027, $ bn
Figure 24. Global Pharmaceutical Manufacturing Industry: Parenteral Medicine, 2017-2027, $ bn
Figure 25. Global Pharmaceutical Manufacturing Industry: Inhalations, 2017-2027, $ bn
Figure 26. Global Pharmaceutical Manufacturing Industry: Other Routes of Administration, 2017-2027, $ bn
Figure 27. Breakdown of Global Pharmaceutical Manufacturing Industry by Age Group, 2020-2027, % of Revenue
Figure 28. Contribution to Global 2021-2027 Cumulative Revenue by Age Group, Value ($ bn) and Share (%)
Figure 29. Global Pharmaceutical Manufacturing Industry: Children & Adolescents, 2017-2027, $ bn
Figure 30. Global Pharmaceutical Manufacturing Industry: Adults, 2017-2027, $ bn
Figure 31. Global Pharmaceutical Manufacturing Industry: Geriatric, 2017-2027, $ bn
Figure 32. Breakdown of Global Pharmaceutical Manufacturing Industry by Therapeutic Application, 2020-2027, % of Revenue
Figure 33. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 34. Global Pharmaceutical Manufacturing Industry: Cardiovascular Diseases, 2017-2027, $ bn
Figure 35. Global Pharmaceutical Manufacturing Industry: Pain, 2017-2027, $ bn
Figure 36. Global Pharmaceutical Manufacturing Industry: Diabetes, 2017-2027, $ bn
Figure 37. Global Pharmaceutical Manufacturing Industry: Cancer, 2017-2027, $ bn
Figure 38. Global Pharmaceutical Manufacturing Industry: Respiratory Diseases, 2017-2027, $ bn
Figure 39. Global Pharmaceutical Manufacturing Industry: Neurological Diseases, 2017-2027, $ bn
Figure 40. Global Pharmaceutical Manufacturing Industry: Orthopedics, 2017-2027, $ bn
Figure 41. Global Pharmaceutical Manufacturing Industry: Other Applications, 2017-2027, $ bn
Figure 42. Breakdown of Global Pharmaceutical Manufacturing Industry by Drug Type, 2020-2027, % of Revenue
Figure 43. Contribution to Global 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 44. Global Pharmaceutical Manufacturing Industry: Branded Prescription Drugs, 2017-2027, $ bn
Figure 45. Global Pharmaceutical Manufacturing Industry: Generic Prescription Drugs, 2017-2027, $ bn
Figure 46. Global Pharmaceutical Manufacturing Industry: OTC Drugs, 2017-2027, $ bn
Figure 47. Breakdown of Global Pharmaceutical Manufacturing Industry by Distribution Channels, 2020-2027, % of Revenue
Figure 48. Contribution to Global 2021-2027 Cumulative Revenue by Distribution Channels, Value ($ bn) and Share (%)
Figure 49. Global Pharmaceutical Manufacturing Industry: Retail Channels, 2017-2027, $ bn
Figure 50. Global Pharmaceutical Manufacturing Industry: Non-retail Channels, 2017-2027, $ bn
Figure 51. Breakdown of Global Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2020-2027, % of Revenue
Figure 52. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturing Facility, Value ($ bn) and Share (%)
Figure 53. Global Pharmaceutical Manufacturing Industry: In-house Facility, 2017-2027, $ bn
Figure 54. Global Pharmaceutical Manufacturing Industry: Outsourced Facility, 2017-2027, $ bn
Figure 55. Global Industry Snapshot by Region
Figure 56. Geographic Spread of Worldwide Pharmaceutical Manufacturing Industry, 2020-2027, % of Revenue
Figure 57. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 58. North American Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 59. Breakdown of North America Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue
Figure 60. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 61. U.S. Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 62. Canada Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 63. Pharmaceutical Manufacturing Industry in Mexico, 2017-2027, $ bn
Figure 64. European Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 65. Breakdown of European Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue
Figure 66. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 67. Pharmaceutical Manufacturing Industry in UK, 2017-2027, $ bn
Figure 68. Pharmaceutical Manufacturing Industry in France, 2017-2027, $ bn
Figure 69. Pharmaceutical Manufacturing Industry in Germany, 2017-2027, $ bn
Figure 70. Pharmaceutical Manufacturing Industry in Spain, 2017-2027, $ bn
Figure 71. Pharmaceutical Manufacturing Industry in Italy, 2017-2027, $ bn
Figure 72. Pharmaceutical Manufacturing Industry in Russia, 2017-2027, $ bn
Figure 73. Pharmaceutical Manufacturing Industry in Rest of Europe, 2017-2027, $ bn
Figure 74. Asia-Pacific Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 75. Breakdown of APAC Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue
Figure 76. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 77. Pharmaceutical Manufacturing Industry in China, 2017-2027, $ bn
Figure 78. Pharmaceutical Manufacturing Industry in Japan, 2017-2027, $ bn
Figure 79. Pharmaceutical Manufacturing Industry in India, 2017-2027, $ bn
Figure 80. Pharmaceutical Manufacturing Industry in Australia, 2017-2027, $ bn
Figure 81. Pharmaceutical Manufacturing Industry in South Korea, 2017-2027, $ bn
Figure 82. Pharmaceutical Manufacturing Industry in Rest of APAC, 2017-2027, $ bn
Figure 83. South America Pharmaceutical Manufacturing Industry, 2017-2027, $ bn
Figure 84. Breakdown of South America Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue
Figure 85. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 86. Pharmaceutical Manufacturing Industry in Argentina, 2017-2027, $ bn
Figure 87. Pharmaceutical Manufacturing Industry in Brazil, 2017-2027, $ bn
Figure 88. Pharmaceutical Manufacturing Industry in Chile, 2017-2027, $ bn
Figure 89. Pharmaceutical Manufacturing Industry in Rest of South America, 2017-2027, $ bn
Figure 90. Pharmaceutical Manufacturing Industry in Middle East and Africa (MEA), 2017-2027, $ bn
Figure 91. Breakdown of MEA Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue
Figure 92. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 93. Pharmaceutical Manufacturing Industry in UAE, 2017-2027, $ bn
Figure 94. Pharmaceutical Manufacturing Industry in Saudi Arabia, 2017-2027, $ bn
Figure 95. Pharmaceutical Manufacturing Industry in South Africa, 2017-2027, $ bn
Figure 96. Growth Stage of Global Industrial Robot Software Industry over the Forecast Period
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Abbott Laboratories
  • Aenova Group
  • Amgen
  • AstraZeneca
  • Catalent Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lonza Group
  • Lupin
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk
  • Pfizer, Inc.
  • Roche
  • Sanofi S.A.
  • Takeda
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll